Tavr

TAVR, or transcatheter aortic valve replacement, is a procedure in which a new aortic valve is placed through a catheter rather than by opening the chest in the traditional way. It is used in selected patients with severe aortic valve disease, especially severe aortic stenosis. ^[1][2][3]

In which patients is TAVR considered?

TAVR is generally considered in patients with severe symptomatic aortic stenosis and, in selected situations, other forms of aortic valve dysfunction when a transcatheter approach is appropriate. The decision is not made based on valve disease alone. Symptoms, age, anatomy, procedural risk, surgical risk, frailty, and overall life expectancy are all relevant. A multidisciplinary heart team usually helps determine whether TAVR, surgical valve replacement, or another strategy is the best fit. ^[3][4][5]

Why is pre-TAVR evaluation so comprehensive?

Pre-procedure evaluation is detailed because success depends heavily on anatomy and overall clinical suitability. Imaging such as echocardiography and CT, vascular access assessment, coronary status, kidney function, and the patient’s broader health all matter. The goal is not only to decide whether the valve should be treated, but also to determine whether a catheter-based route can be done safely and effectively. ^[1][4][6]

How is the procedure performed?

During TAVR, a replacement valve is delivered through a catheter, most often via the femoral artery, and positioned within the diseased aortic valve. The procedure is generally less invasive than open surgery, but it is still a major heart intervention requiring expert planning, imaging, and monitoring. Different anesthesia and access strategies may be used depending on the patient and center. ^[1][2][6]

What is the advantage compared with open surgery?

A major advantage is that TAVR can offer treatment to patients who may benefit from a less invasive approach, sometimes with shorter recovery and earlier mobilization than open-heart surgery. Even so, “less invasive” does not mean minor or risk-free. The best choice still depends on anatomy, age, durability considerations, and the patient’s long-term treatment goals. ^[1][3][4]

What are the possible risks and complications?

Recognized risks include bleeding, stroke, vascular injury, kidney problems, valve leak, rhythm problems requiring pacemaker implantation, infection, and other procedure-related complications. These are important reasons why TAVR should be performed in experienced centers with structured follow-up. The fact that it avoids open surgery does not remove the need for rigorous assessment. ^[2][4][6][7]

How does life change after TAVR?

Many patients experience improvement in symptoms such as shortness of breath, fatigue, and exercise tolerance, but follow-up remains essential. Recovery still includes medication review, imaging follow-up, attention to rhythm issues, and ongoing management of other cardiac disease. TAVR improves a valve problem; it does not automatically erase all other heart-related health concerns. ^[1][3][6]

When is urgent help needed?

Urgent review is needed for chest pain, new neurologic symptoms, severe shortness of breath, worsening swelling, fever, fainting, major bleeding, or any sudden significant decline after the procedure. Some complications are uncommon but time-sensitive and should not be watched passively. ^[2][4][7]

Conclusion

TAVR is an important structural heart treatment option for selected patients with severe aortic valve disease. Its value lies in careful patient selection, high-quality imaging and planning, experienced procedural care, and structured follow-up afterward. ^[1][3][4]

Is age alone enough to make the decision?

No. Although age is one factor, it is not the only one. Frailty, anatomy, comorbid disease, life expectancy, and the balance between catheter-based and surgical options all matter. A younger patient is not automatically unsuitable, and an older patient is not automatically ideal. The decision should be individualized. ^[4][5][7]